ClinicalTrials.Veeva

Menu

Effect of Glutamine on Urinary Incontinence

I

Istanbul University

Status

Completed

Conditions

Urinary Incontinence

Treatments

Dietary Supplement: glutamine supplementation
Dietary Supplement: fantomalt supplementation

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT03265509
2014/1203

Details and patient eligibility

About

The objective of this study is to determine to effect of additional oral glutamine to Kegel exercises on pelvic floor strength and clinical parameters of urinary incontinence in females with either urinary incontinence (stress and/or urgency) and pelvic prolapse.

Full description

Urinary incontinence is a prevalent and costly condition that affects approximately 38% of older community-dwelling women (age>60 years). Incontinence predisposes patients to other health problems, contributes to depression and social isolation, is a significant source of dependency among the elderly, and is widely cited as a factor in nursing home admissions. Sarcopenia is age-related and is characterized by loss of muscle mass, strength and endurance. There is not only a decrease in the number of muscle fibers, but also atrophy in the remaining ones. Several studies indicate glutamine supplementations lead to better muscle performance by stimulate muscle producing in extremities. Similarly, we assume glutamine supplementation could increase pelvic muscle mass and improve the pelvic floor strength. From this point, using glutamine supplementation may effect positively on stress, urge or mixed incontinence, and pelvic prolapse.

Enrollment

50 patients

Sex

Female

Ages

45 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Presence of urinary incontinence and/or pelvic prolapse and/or decreased vaginal muscle strength in gynaecological examination

Exclusion criteria

  • Uncontrolled diabetes
  • Cognitive dysfunction hampering participation in exercise or assessment

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

50 participants in 2 patient groups, including a placebo group

Glutamine
Active Comparator group
Description:
30 g/day Glutamine supplementation for three months
Treatment:
Dietary Supplement: glutamine supplementation
Fantomalt
Placebo Comparator group
Description:
30 g/day Fantomalt supplementation for three months
Treatment:
Dietary Supplement: fantomalt supplementation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems